Overcoming hurdles in cancer immunotherapy
- PMID: 33597747
- DOI: 10.1038/s41579-021-00526-7
Overcoming hurdles in cancer immunotherapy
Republished in
-
Overcoming hurdles in cancer immunotherapy.Nat Rev Cancer. 2021 Apr;21(4):214-215. doi: 10.1038/s41568-021-00343-3. Nat Rev Cancer. 2021. PMID: 33619387 No abstract available.
Comment on
-
Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients.Science. 2021 Feb 5;371(6529):602-609. doi: 10.1126/science.abb5920. Epub 2020 Dec 10. Science. 2021. PMID: 33303685 Clinical Trial.
-
Fecal microbiota transplant overcomes resistance to anti-PD-1 therapy in melanoma patients.Science. 2021 Feb 5;371(6529):595-602. doi: 10.1126/science.abf3363. Science. 2021. PMID: 33542131 Free PMC article. Clinical Trial.
References
Original articles
-
- Baruch, E. N. et al. Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients. Science 371, 602–609 (2021) - DOI
-
- Davar, D. & Dzutsev, A. K. et al. Fecal microbiota transplant overcomes resistance to anti–PD-1 therapy in melanoma patients. Science 371, 595–602 (2021) - DOI
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical